AMGEN TO PRESENT DATA FROM MULTIPLE EARLY-STAGE CLINICAL TRIALS AT ESMO 2024
Amgen presents new oncology data at ESMO Congress 2024, highlighting targeted therapies for colorectal, lung, prostate, and gastric cancers, reflecting its strategy to advance diverse modalities for difficult-to-treat cancers.
Related Clinical Trials
Reference News
Amgen presents new oncology data at ESMO Congress 2024, highlighting targeted therapies for colorectal, lung, prostate, and gastric cancers, reflecting its strategy to advance diverse modalities for difficult-to-treat cancers.
Amgen presents new oncology data at ESMO Congress 2024, highlighting targeted therapies for colorectal, lung, prostate, and gastric cancers, reflecting their strategy to advance diverse modalities for difficult-to-treat cancers.
Amgen presents new oncology data at ESMO 2024, highlighting targeted therapies for colorectal, lung, prostate, and gastric cancers, reflecting its strategy to advance diverse modalities for difficult-to-treat cancers.